Peg Crowley-Nowick’s Post

J.P. Morgan Global Healthcare Conference January 9th to 11th 2024: What are the key talking points likely to be? Potential big news stories that could break at the J.P. Morgan Global Healthcare Conference in January 2024 include: A major pharmaceutical company could announce a breakthrough new drug or therapy. The conference is a major platform for pharmaceutical companies to announce their latest developments, and it is possible that a major company could announce a breakthrough new drug or therapy at the event. A digital health company could announce a major new partnership or investment. Digital health is one of the most rapidly growing sectors in healthcare, and it is likely that a major digital health company could announce a major new partnership or investment at the conference. A healthcare provider could announce a major new initiative to improve access or quality of care. The conference is also a platform for healthcare providers to announce new initiatives, and it is possible that a major provider could announce a major new initiative to improve access or quality of care at the event. A government agency could announce a new policy or initiative related to healthcare. The conference is also attended by government officials, and it is possible that a government agency could announce a new policy or initiative related to healthcare at the event. In addition to these specific news stories, the conference is also likely to feature a number of announcements about new research findings, clinical trial results, and other developments in the healthcare industry. #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors https://lnkd.in/e9EzxWrr

October is coming and with it the 17th Annual Optimizing Clinical Trials Summit. Join the most interactive and beneficial Clinical Trials event in EUROPE to meet/discuss with the most well known pharma companies (GSK, Roche, Sanofi, Takeda, Servier, Lilly, Bayer and more....) to keep up to date with the newest trends and proven approaches and make real business. -for more info contact me directly @cloe.gjoci@allanlloyds.com #clinicaltrials #clinicalresearch #feasibility #siteselection #randomizedtrials #decentralisedtrials #patientrecruitment #patient #clinical #trialmanagement #sitemanagement #virtualtrials #clinicalinnovations #siteengagement #summit #event #pharma #pfizer #gsk #roche #iqvia #astrazeneca #conferences2023  #decentralizedtrials #decentralizedclinicaltrials #oct2023

Here are some highlights you can expect visiting Sannova at booth # 223 at SCOPE 2024. ☑️Learn how our digital transformation is redefining outsourcing, breaking down communication barriers and blending expertise. ☑️Discover how our Z-factor approach enhances our workflows, improving sensitivity and specificity for both preclinical and clinical studies. ☑️Extensive track record of FDA method validation and comprehensive, high quality CMC services. ☑️And of course, conversations with our friendly and passionate team. #SCOPE2024 #ClinicalTrials #CRO #Pharma #DigitalTransformation

I really enjoyed challenging the #dpharm2023 audience to think holistically about the process of bringing innovative approaches to clinical trials in a large pharma environment. In a world where adding value is the most important aspect of innovation in any industry, it is an important reminder to ensure that any active player in the clinical operations space (vendor, sponsor, CRO partner) that brings innovative solutions must focus on delivering and measuring the value of that innovation to the stakeholders that need it most - patients and sites. Happy to discuss and exchange further ideas with anyone wanting to know more! #dpharm2023 #clinicaltrials #innovation #valueadd #capabilities #clinicalinnovation

At #DPHARM2023, Hassan Kadhim shared how Bristol Myers Squibb organizes its clinical technology business capabilities organization to enable clinical trials end-to-end. Hassan Kadhim also taught the audience how to understand that the adoption of a new technology solution within one business capability not only impacts that specific business capability but also the potential ripple effect on other business capabilities. Learn more about the 13th annual program here - dpharmconference.com #DPHARM2023 #pharma #patientadvocate #patientengagement

Join us for some great 2024 insights from Ken Getz and Jim Murphy on this upcoming webinar!

In 2020, Boehringer Ingelheim embarked on a three-year Medical Excellence Journey with the goal of accelerating clinical development speed and improving patient access. This journey focused on the seamless integration of end-to-end strategic planning and execution. Today at #DPHARM2023, Dr Stefan Kaspers discussed key elements of the BI approach, lessons learned, initial outcomes, and more. Learn more about the 13th annual program here - dpharmconference.com #DPHARM2023 #pharma #patientadvocate #patientengagement

When it comes to AI and medical affairs' evolving role in the life sciences, the real winners will be the early adopters of this technology and practices who are agile enough to make changes as new information becomes available. To get an early leg-up on your AI adoption, make sure to attend our upcoming webinar on June 25. The Envision and panel experts will go beyond the theoretical, offering a concrete vision of how AI can redefine every facet of medical work, creating a more efficient and effective pharmaceutical environment! https://lnkd.in/dKjvQS2K

Find out about the future of clinical trials: